Work

WT1 Peptide Vaccine Is Able to Induce WT1-Specifc Immune Response with TCR Clonal Enrichment to Control Minimal Residual Disease in Patients with Myeloid Leukemia

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.3984.3984

Authors: Hongtao Liu, Yuanyuan Zha, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, Yusuke Nakamura, Richard A. Larson, Andres M Salazar, Olatoyosi Odenike, Thomas Gajewski, Wendy Stock

Institutions: University of Chicago Medical Center, University of Chicago, Oncovir (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600469406

FWCI: 0.168

Cites:

Cited by: 2

Related to: 10